To elucidate the effects of 2ccPA on inflammation resulting from TBI, we analysed the mRNA expression of inflammatory cytokines

To elucidate the effects of 2ccPA on inflammation resulting from TBI, we analysed the mRNA expression of inflammatory cytokines. inflammation after TBI. Introduction Traumatic brain injury (TBI) occurs following physical brain damage due to a variety of causes such as road traffic accidents and falls. It affects approximately 10 million people worldwide per year. TBI severity and prognosis are associated with the impact of the primary and secondary brain injury. Main brain injury refers to the mechanical damage including axonal loss and haemorrhage. Secondary brain injury occurs after several minutes to days of the primary brain injury. Rabbit Polyclonal to SLC5A2 The secondary brain injury is usually caused by oedema and ischemia due to inflammation, cell death, and gliosis1. The secondary brain injury has a significant impact on the TBI end result. To attenuate unfavorable effects of TBI, it is very important to alleviate the impact of the secondary brain injury. Lysophosphatidic acid (LPA) is usually a lipid mediator. LPA was found to be elevated in the cerebrospinal fluid of TBI patients and of mice in a TBI model2. In a zebrafish model of spinal cord injury (SCI), LPA administration increased glial cell proliferation and neuronal cell death, indicating that LPA exerts proinflammatory activity and plays an inhibitory role in neuroregeneration after nerve Heparin sodium injury3. It has been exhibited that blocking LPA signalling with LPA-antibodies reduces lesion volume and diminishes tissue damage in mouse models of SCI and TBI2,3. LPA is usually generated by enzymatic hydrolysis of lysophosphatidylcholine catalysed by autotaxin (ATX)4, and it has been reported that ATX-mediated LPA production is usually induced 2C3?hours after nerve injury5. Therefore, decreasing LPA production and/or inhibiting its function after brain injury may diminish the secondary injury after TBI and thus attenuate the sequelae of TBI. Cyclic phosphatidic acid (cPA) is usually a lipid mediator, which is also generated by ATX6. Although the chemical formula of cPA is similar to that of LPA, cPA has a unique structure consisting of a cyclic phosphate ring at the studies revealed that cPA elicits neurotrophin-like actions9,11 and protects neurons from mitochondrial dysfunction-induced apoptosis12. In Heparin sodium an study, cPA attenuated ischemia-induced delayed neuronal death in rat hippocampal CA1 regions13. Additionally, cPA reduced the extent of demyelination, astrogliosis, microglial activation, and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model14. Moreover, it is known that cPA inhibits ATX activity15. Thus, cPA could be an endogenous inhibitor of LPA production ATX inhibition. These results led us to investigate the effects of cPA on TBI. In this study, we used a metabolically stabilised derivative of cPA; 2-carba-cyclic phosphatidic acid (2ccPA) is usually a compound in which the phosphate oxygen is usually replaced by a methylene group at the mRNA expression levels. The primer sequences used in the present study are outlined in Table?112,19C23. mRNA expression levels were quantified using a KOD SYBR qPCR Mix (Toyobo Co., Ltd.) with an ABI 7300 real-time PCR machine (Thermo Fisher Scientific, Waltham, MA). Analyses of relative gene expression levels were performed using the 2 2?Delta-Delta-Ct method between contralateral and injured cortices to reduce individual differences. Table 1 Primer sequences utilized for real-time RT-PCR. are increased in mouse cerebral cortices after application of a stab wound20,26. In the present study, mRNA expression levels of were quantified in TBI model mice receiving 2ccPA. Near the cortical lesions, the mRNA expression of the pro-inflammatory cytokines was increased in both control and 2ccPA-treated mice, reaching maximal values at day 1. However, the administration of 2ccPA significantly suppressed the mRNA expression of on days 3C7, on days 5 and 7, and on day 5 (Fig.?2ACC). In addition, 2ccPA administration inhibited the injury-induced up-regulation of mRNA expression on day 3 (Fig.?2D). In na?ve mice, the cortical mRNA expression of was not significantly affected by the administration of 2ccPA at any investigated time point (Supplementary Fig.?S2ACC). Open in a separate window Heparin sodium Physique 2 mRNA expression levels of pro- and anti-inflammatory cytokines near the stab wound injury in the cerebral cortices of 2ccPA-treated mice. (ACD) Real-time RT-PCR analyses of mRNA expression on days 1, 3, 5, and 7 in PBS (control)- and 2ccPA-treated mice. mRNA expression levels were normalised to those of and were subsequently normalised to the corresponding expression levels of.